AnaptysBio Operating Income vs Interest Income Analysis

ANAB Stock  USD 26.58  0.24  0.91%   
AnaptysBio financial indicator trend analysis is way more than just evaluating AnaptysBio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AnaptysBio is a good investment. Please check the relationship between AnaptysBio Operating Income and its Interest Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AnaptysBio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.

Operating Income vs Interest Income

Operating Income vs Interest Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AnaptysBio Operating Income account and Interest Income. At this time, the significance of the direction appears to have pay attention.
The correlation between AnaptysBio's Operating Income and Interest Income is -0.93. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Interest Income in the same time period over historical financial statements of AnaptysBio, assuming nothing else is changed. The correlation between historical values of AnaptysBio's Operating Income and Interest Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of AnaptysBio are associated (or correlated) with its Interest Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Income has no effect on the direction of Operating Income i.e., AnaptysBio's Operating Income and Interest Income go up and down completely randomly.

Correlation Coefficient

-0.93
Relationship DirectionNegative 
Relationship StrengthSignificant

Operating Income

Operating Income is the amount of profit realized from AnaptysBio operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of AnaptysBio is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.
Most indicators from AnaptysBio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AnaptysBio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AnaptysBio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.At present, AnaptysBio's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 2.57, whereas Tax Provision is forecasted to decline to (4.2 K).
 2021 2022 2023 2024 (projected)
Interest Expense1.5M21.1M18.1M19.0M
Depreciation And Amortization468K7.6M2.4M2.8M

AnaptysBio fundamental ratios Correlations

0.660.560.820.820.690.8-0.64-0.720.50.660.86-0.180.990.79-0.460.620.750.780.650.640.990.450.790.660.93
0.660.520.490.280.760.49-0.32-0.580.00.370.720.050.610.35-0.520.750.60.570.740.720.620.260.30.570.64
0.560.520.640.080.850.53-0.11-0.960.110.140.44-0.230.560.53-0.280.90.790.910.910.910.57-0.090.460.970.78
0.820.490.640.590.570.87-0.27-0.80.680.30.63-0.110.820.77-0.510.590.80.710.620.60.830.320.70.630.85
0.820.280.080.590.170.64-0.67-0.270.60.680.64-0.060.840.62-0.410.080.430.390.110.110.830.60.680.20.64
0.690.760.850.570.170.54-0.35-0.870.060.390.67-0.260.660.55-0.240.980.730.870.980.980.67-0.010.520.890.8
0.80.490.530.870.640.54-0.51-0.660.520.530.59-0.120.820.71-0.630.510.650.690.540.520.820.180.680.590.76
-0.64-0.32-0.11-0.27-0.67-0.35-0.510.2-0.26-1.0-0.36-0.01-0.68-0.390.27-0.19-0.21-0.46-0.19-0.26-0.68-0.06-0.44-0.3-0.46
-0.72-0.58-0.96-0.8-0.27-0.87-0.660.2-0.35-0.24-0.580.21-0.71-0.660.33-0.91-0.88-0.92-0.93-0.92-0.72-0.07-0.6-0.94-0.89
0.50.00.110.680.60.060.52-0.26-0.350.250.310.240.520.41-0.330.050.40.230.090.080.520.260.410.090.46
0.660.370.140.30.680.390.53-1.0-0.240.250.40.010.710.4-0.290.240.240.490.240.30.70.070.450.330.5
0.860.720.440.630.640.670.59-0.36-0.580.310.4-0.230.80.65-0.350.620.570.610.630.590.80.480.680.520.76
-0.180.05-0.23-0.11-0.06-0.26-0.12-0.010.210.240.01-0.23-0.16-0.64-0.41-0.23-0.19-0.23-0.23-0.26-0.16-0.31-0.66-0.25-0.27
0.990.610.560.820.840.660.82-0.68-0.710.520.710.8-0.160.79-0.460.590.750.790.620.621.00.420.790.660.93
0.790.350.530.770.620.550.71-0.39-0.660.410.40.65-0.640.79-0.040.510.640.670.530.540.790.440.980.590.8
-0.46-0.52-0.28-0.51-0.41-0.24-0.630.270.33-0.33-0.29-0.35-0.41-0.46-0.04-0.26-0.45-0.32-0.29-0.25-0.47-0.21-0.03-0.27-0.43
0.620.750.90.590.080.980.51-0.19-0.910.050.240.62-0.230.590.51-0.260.760.861.00.990.6-0.020.460.90.78
0.750.60.790.80.430.730.65-0.21-0.880.40.240.57-0.190.750.64-0.450.760.760.790.790.760.420.590.750.91
0.780.570.910.710.390.870.69-0.46-0.920.230.490.61-0.230.790.67-0.320.860.760.870.870.79-0.030.650.970.88
0.650.740.910.620.110.980.54-0.19-0.930.090.240.63-0.230.620.53-0.291.00.790.870.990.620.010.480.910.81
0.640.720.910.60.110.980.52-0.26-0.920.080.30.59-0.260.620.54-0.250.990.790.870.990.630.00.490.910.81
0.990.620.570.830.830.670.82-0.68-0.720.520.70.8-0.161.00.79-0.470.60.760.790.620.630.420.790.670.93
0.450.26-0.090.320.6-0.010.18-0.06-0.070.260.070.48-0.310.420.44-0.21-0.020.42-0.030.010.00.420.47-0.090.41
0.790.30.460.70.680.520.68-0.44-0.60.410.450.68-0.660.790.98-0.030.460.590.650.480.490.790.470.550.79
0.660.570.970.630.20.890.59-0.3-0.940.090.330.52-0.250.660.59-0.270.90.750.970.910.910.67-0.090.550.81
0.930.640.780.850.640.80.76-0.46-0.890.460.50.76-0.270.930.8-0.430.780.910.880.810.810.930.410.790.81
Click cells to compare fundamentals

AnaptysBio Account Relationship Matchups

AnaptysBio fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets435.2M416.6M643.1M610.4M452.4M354.3M
Short Long Term Debt Total2.2M342K21.0M19.5M17.8M10.8M
Other Current Liab871K15.3M12.9M21.6M31.0M32.5M
Total Current Liabilities29.5M19.8M16.1M26.1M37.4M19.3M
Total Stockholder Equity405.0M396.7M356.4M262.1M88.1M83.7M
Property Plant And Equipment Net1.6M1.8M21.8M20.0M18.3M19.2M
Net Debt(168.8M)(250.1M)(474.8M)(51.9M)(18.2M)(19.1M)
Retained Earnings(244.0M)(264.0M)(321.8M)(450.5M)(614.1M)(583.4M)
Accounts Payable16.2M4.2M1.7M2.8M4.7M4.2M
Cash171.0M250.5M495.7M71.3M36.0M34.2M
Non Current Assets Total57.5M20.0M89.2M163.2M45.6M53.5M
Non Currrent Assets Other208K1.5M662K256K230.4K218.9K
Cash And Short Term Investments374.2M393.7M548.1M441.2M390.9M295.2M
Common Stock Shares Outstanding27.1M27.3M27.4M28.2M26.9M21.0M
Liabilities And Stockholders Equity435.2M416.6M643.1M610.4M452.4M354.3M
Non Current Liabilities Total654K4.6M270.5M322.2M326.8M343.2M
Other Current Assets3.5M2.9M4.9M4.5M9.1M9.5M
Other Stockholder Equity213.5M660.7M678.6M717.8M703.0M738.1M
Total Liab30.2M19.8M286.6M348.3M364.3M382.5M
Property Plant And Equipment Gross1.6M1.8M21.8M20.0M24.5M25.7M
Total Current Assets377.7M396.6M553.9M447.2M406.8M300.8M
Accumulated Other Comprehensive Income338K(4K)(422K)(5.2M)(797K)(836.9K)
Short Term Debt2.2M342K1.5M1.6M1.8M2.3M
Other Liab796K654K251.1M304.4M350.1M367.6M
Net Tangible Assets405.0M396.7M627.0M584.3M672.0M705.6M
Other Assets208K139K18.2M256K294.4K279.7K
Property Plant Equipment3.0M1.8M2.3M2.1M2.4M1.6M
Capital Surpluse648.7M660.7M678.6M717.8M825.5M517.6M
Retained Earnings Total Equity(244.0M)(264.0M)(321.8M)(450.5M)(405.4M)(385.2M)
Short Term Investments203.2M143.2M52.4M369.9M354.9M252.1M
Capital Lease Obligations871K342K21.0M19.5M17.8M9.4M
Net Invested Capital406.4M396.7M356.4M262.1M88.1M83.7M
Long Term Investments54.3M17.5M67.1M142.9M27.0M25.7M

Pair Trading with AnaptysBio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AnaptysBio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will appreciate offsetting losses from the drop in the long position's value.

Moving together with AnaptysBio Stock

  0.61EGRX Eagle Pharmaceuticals Earnings Call This WeekPairCorr

Moving against AnaptysBio Stock

  0.64QLI Qilian InternationalPairCorr
  0.49SNDL SNDL Inc Earnings Call This WeekPairCorr
  0.48CGC Canopy Growth Corp Financial Report 27th of June 2024 PairCorr
The ability to find closely correlated positions to AnaptysBio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AnaptysBio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AnaptysBio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AnaptysBio to buy it.
The correlation of AnaptysBio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AnaptysBio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AnaptysBio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AnaptysBio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AnaptysBio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AnaptysBio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anaptysbio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anaptysbio Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AnaptysBio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.
Note that the AnaptysBio information on this page should be used as a complementary analysis to other AnaptysBio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for AnaptysBio Stock analysis

When running AnaptysBio's price analysis, check to measure AnaptysBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnaptysBio is operating at the current time. Most of AnaptysBio's value examination focuses on studying past and present price action to predict the probability of AnaptysBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnaptysBio's price. Additionally, you may evaluate how the addition of AnaptysBio to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Transaction History
View history of all your transactions and understand their impact on performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Is AnaptysBio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AnaptysBio. If investors know AnaptysBio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AnaptysBio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.08)
Revenue Per Share
0.637
Quarterly Revenue Growth
0.323
Return On Assets
(0.18)
Return On Equity
(0.93)
The market value of AnaptysBio is measured differently than its book value, which is the value of AnaptysBio that is recorded on the company's balance sheet. Investors also form their own opinion of AnaptysBio's value that differs from its market value or its book value, called intrinsic value, which is AnaptysBio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AnaptysBio's market value can be influenced by many factors that don't directly affect AnaptysBio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AnaptysBio's value and its price as these two are different measures arrived at by different means. Investors typically determine if AnaptysBio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AnaptysBio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.